Events
Duane Morris Special Counsel Michael Swit to Speak on "Crisis Management for the
FDA-Regulated Company"
May 22, 2012 | Audio Conference
Duane Morris special counsel Michael Swit will be presenting on the subject of "Crisis Management for the FDA-Regulated Company" at an FX Conference audio conference on Tuesday, May 22, 2012.
At any moment, lightning can strike your FDA-regulated company. It may take the form of an unexpected serious adverse event such as a death attributed to your product forcing you to consider a recall—or an FDA inspection exposing severe quality issues—or a tampering incident such as J&J faced twice with TylenolŪ. Regardless of how the crisis arises, it is vital that your firm be prepared in advance to address the crisis immediately and responsibly. This audio conference will review key issues that FDA-regulated firms will face arising during a crisis related to products or operations regulated by FDA and how to respond to them. Using the backdrop of an actual case study that the speaker was directly involved with—the Generic Drug Scandal that rocked FDA and industry during the late 80's— we will review how to be prepared for a crisis and how to respond to it when it arises. While one never thinks they will be hit by lightning, this audio conference will help you be prepared when, on that rare day, it does. Indeed, if you are not prepared before you're hit, it likely will be too late to react in the best manner to protect not only the public health, but also to responsibly mitigate the impact on your company and all its stakeholders from employees to shareholders.
For additional information, or to register, please visit the FX Conferences website.
